Return to home page
Searching: Otterbein library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title Synthesis of therapeutic oligonucleotides / Satoshi Obika, Mitsuo Sekine, editors.
Imprint Singapore : Springer, 2018.

View online
View online
Subject Oligonucleotides.
Alt Name Obika, Satoshi,
Sekine, Mitsuo, 1949-
Description 1 online resource
polychrome rdacc
Note Online resource; title from PDF title page (EBSCO, viewed December 11, 2018)
Bibliography Note Includes bibliographical references.
Contents Intro; Preface; Contents; Part I: Synthesis of Natural Oligonucleotides; Non-protected Synthesis ofOligonucleotides; 1 Introduction; 2 Development ofProton-Block Strategy fortheSynthesis ofOligonucleotides WithoutBase Protection; 3 Development oftheActivated Phosphite Method Using N-Unprotected Phosphoramidites; 4 Mechanism oftheActivated Phosphite Method; 5 Synthesis ofRNA Oligomers Using theActivated Phosphite Method; 6 Synthesis ofPhosphoramidite Monomer Building Blocks; 7 Conclusion; References
Various Coupling Agents inthePhosphoramidite Method forOligonucleotide Synthesis1 Introduction; 2 Coupling Agents inthePhosphoramidite Method; 2.1 1H-Tetrazole andIts Derivatives; 2.1.1 1H-Tetrazole; 2.1.2 5-Ethylthio-1H-tetrazole; 2.1.3 5-Benzylthio-1H-tetrazole; 2.1.4 5-[3,5-Bis(trifluoromethyl)phenyl]-1H-tetrazole (Activator 42); 2.2 4,5-Dicyanoimidazole; 2.3 Carboxylic Acids; 2.4 Acid/Azole Complexes; 3 Conclusion; References; Recent Development ofChemical Synthesis ofRNA; 1 Introduction; 2 Basic Principle ofSolid-Phase Synthesis ofDNA/RNA inPhosphoramidite Approach
3 Current RNA Synthesis Using TBDMS as2′-Hydroxyl Protecting Group4 RNA Synthesis Using Acid-Labile 2′-Hydroxyl Protecting Groups; 5 RNA Synthesis Using 2′-Protecting Groups Having anAcetal Skeleton; 5.1 (2-Nitrobenzyl)oxymethyl (NBOM) Group; 5.2 2-(Trimethylsilyl)ethoxymethyl (SEM) Group; 6 RNA Synthesis Using theTriisopropylsilyloxymethyl (Tom) Group; 7 Cyanoethoxy-1-Methylethyl (CEE) andCyanoethoxymethyl (CEM) Groups; 8 RNA Synthesis Using 4-Methylphenylsulfonylethoxymethyl (TEM) Group; 9 RNA Synthesis Using tert-Butyldithiomethyl (DTM) Group
10 RNA Synthesis Using [[2-(Methylthio)phenyl]thio]methyl (MPTM) Group11 RNA Synthesis Using (N-Dichloroacetyl-N-methyl)aminobenzyloxylmethyl (DCMABOM) Group; 12 RNA Synthesis Using theAcetal Levulinyl Ester (ALE) Group; 13 RNA Synthesis Using theCyanoethyl (CE) Group; 14 RNA Synthesis Without Using Base Protection; 15 Recent Studies onRNA Chemical Synthesis; 16 Summary andPerspectives; References; RNA Synthesis Using theCEM Group; 1 Introduction; 2 Synthesis ofCEM Amidites; 3 Synthesis ofRNA; 4 Experimental Section; 4.1 Preparation ofCEM-SMe
4.2 Synthesis ofU-CEM Phosphoramidite (5a.)4.2.1 32 52 O-(Tetraisopropyldisiloxane-1,3-diyl)-22 O-(2-cyanoethoxymethyl)uridine (2a.); 4.2.2 22 O-(2-Cyanoethoxymethyl)uridine (3a.); 4.2.3 52 O-(4,42 Dimethoxytrityl)-22 O-(2-xyanoethoxymethyl)uridine (4a.); 4.2.4 52 O-(4,42 Dimethoxytrityl)-22 O-(2-cyanoethoxymethyl)uridine 32 O-(2-Cyanoethyl N, N-diisopropylphosphoramidite) (5a.); 4.3 Synthesis ofC-CEM Phosphoramidite (5b.); 4.3.1 4-N-Acetyl-32 52 O-(tetraisopropyldisiloxane-1,3-diyl)-22 O-(2-cyanoethoxymethyl)cytidine (2b.); 4.3.2 4-N-Acetyl-22 O-(2-cyanoethoxymethyl)cytidine (3b.)
Summary This book presents the latest knowledge on a broad range of topics relating to the synthesis of natural and artificial oligonucleotides with therapeutic potential. Nucleic acid-based therapeutics are attracting much attention, and numerous therapeutic oligonucleotides, such as antisense oligonucleotides, siRNAs, splice-switching oligonucleotides, and nucleic acid aptamers, are being evaluated in clinical trials for the treatment of a variety of diseases. Synthesis of Therapeutic Oligonucleotides covers a broad range of topics in the field that are of high relevance to researchers, including the synthesis of natural and chemically modified oligonucleotides, the development of novel nucleic acid analogs, industrial scale synthesis and purification of oligonucleotides, and important aspects of chemistry, manufacturing, and controls (CMC). The aim is to provide new insights and inspire fresh ideas in nucleic acid chemistry that may ultimately lead to novel concepts and techniques and the discovery of more effective nucleic acid drugs. The book will be of high value for both established researchers in the field and students intending to specialize in nucleic acid chemistry research.
ISBN 9789811319129 (electronic bk.)
981131912X (electronic bk.)
ISBN/ISSN 10.1007/978-981-13-1912-9
OCLC # 1078636561
Additional Format Print version: Synthesis of therapeutic oligonucleotides. Singapore : Springer, 2018 9811319111 9789811319112 (OCoLC)1042353324.

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team